Related Experiment Video
Updated: Aug 13, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
A multifactorial study (cell kinetics, cytogenetics, DNA content) of lung tumours: basic information for prognostic
1Institute of Pathological Anatomy, University of Milan, Italy.
Basic and Applied Histochemistry
|January 1, 1989
Summary
This study on lung tumors found significant variability in proliferative activity and karyotype, with no clear correlation to tumor type. Diploid DNA content doesn't always mean a normal karyotype in lung cancer prognosis.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Lung tumors exhibit diverse biological characteristics.
- Prognostic markers are crucial for predicting patient outcomes in lung cancer.
- Understanding the relationship between proliferation, karyotype, and DNA content is key.
Purpose of the Study:
- To investigate the correlation between prognostic parameters (labeling index, chromosomal pattern, DNA content) and histologic type in lung tumors.
- To assess the variability of proliferative activity and karyotype in lung cancer.
- To determine if diploid DNA content correlates with a normal karyotype.
Main Methods:
- Analysis of 32 lung tumor cases.
- Evaluation of labeling index for proliferative activity.
- Karyotyping to determine chromosomal patterns.
- DNA content analysis.
Main Results:
- Observed significant variability in proliferative activity and karyotype among lung tumors.
- Found no consistent correlation between these parameters and histologic tumor type.
- Demonstrated that diploid DNA content does not guarantee a normal karyotype.
Conclusions:
- Proliferative activity and karyotype show high variability in lung tumors, independent of histologic type.
- Diploid DNA content is not a reliable indicator of a normal karyotype in lung cancer.
- Further patient follow-up is needed for a precise evaluation of prognostic significance.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...